What strikes me most about this data is how purposeful these women are. They're not using cannabis casually — they've often already tried other things, hit dead ends with conventional options, and landed here out of genuine desperation for a decent night's sleep or a break from the aching. That deserves honest information, not judgment or hype.
Learn more about Rose →Sleep problems are the single most cited reason midlife women report using cannabis, appearing in virtually every survey on the topic. The endocannabinoid system plays a documented role in regulating sleep architecture, and THC in particular has been shown to reduce the time it takes to fall asleep — though it also suppresses REM sleep with regular use, which is a real trade-off worth knowing. Women experiencing the frequent nighttime awakenings that define perimenopausal sleep disruption often describe cannabis, particularly CBD-dominant or balanced formulas, as the first thing that has reliably helped.
Anxiety that arrives or intensifies during perimenopause — often described as a new, out-of-nowhere dread — is the second most commonly reported reason women turn to cannabis. Fluctuating estrogen directly affects the GABA and serotonin systems that regulate anxiety, creating a neurological vulnerability that many women find deeply unsettling. CBD has demonstrated anxiolytic effects in several clinical trials at specific doses, though the dose-response curve is non-linear, meaning more is not always better.
Survey data consistently shows hot flashes and night sweats in the top three reasons women cite for cannabis use during menopause. The mechanism is plausible: the endocannabinoid system is involved in thermoregulatory signaling, and CB1 receptors are present in the hypothalamus, the brain region that malfunctions during vasomotor symptoms. Human clinical evidence remains limited, but the biological rationale is sound enough to make this one of the more actively researched areas in cannabis and menopause science.
Many women are surprised to discover that the joint stiffness and diffuse muscle aching that arrives in their mid-forties has a hormonal component — estrogen has significant anti-inflammatory effects, and its decline changes how pain is processed throughout the body. Cannabis, particularly formulations with both CBD and THC, has demonstrated pain-modulating effects via CB1 and CB2 receptors in the peripheral and central nervous systems. Survey respondents frequently report this as a symptom they manage with topical or low-dose oral cannabis rather than seeking prescription pain medication.
The rapid mood shifts of perimenopause — irritability, tearfulness, a short fuse that feels foreign to the person experiencing it — are neurologically driven by estrogen's role in dopamine and serotonin regulation. Women in surveys describe using cannabis, often in low doses and CBD-forward products, to take the edge off emotional volatility without the sedation or side effects they associate with antidepressants. The evidence here is more anecdotal than clinical, but the frequency with which this reason appears across multiple independent surveys gives it real weight.
Genitourinary syndrome of menopause — which includes vaginal dryness, tissue thinning, and painful intercourse — is among the most undertreated menopause symptoms, partly because women are reluctant to raise it with clinicians. Surveys show a meaningful subset of cannabis-using women report using it specifically to reduce the pain and anxiety associated with sex, as well as to increase desire and sensation. Some preliminary research suggests cannabis may increase blood flow to pelvic tissue and modulate pain perception, though rigorous clinical trials in this specific context are still sparse.
Cognitive symptoms — forgetting words, losing a train of thought, feeling mentally slower than usual — are among the most distressing early perimenopause experiences, and women in surveys report turning to cannabis primarily to manage the anxiety and sleep deprivation that amplify them. The relationship between cannabis and cognition is genuinely complex: acute THC use can impair working memory, while better sleep and reduced anxiety (both potentially supported by cannabis) are known to improve cognitive performance. This is one area where formulation and dose matter enormously, and where the evidence is most mixed.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.